所有版本 - 学术资源搜索

[HTML][HTML] C-reactive protein levels predict responses to PD-1 inhibitors in hepatocellular carcinoma patients

Y Zhang, L Lu, Z He, Z Xu, Z Xiang, RC Nie… - Frontiers in …, 2022 - frontiersin.org

Background Serum C-reactive protein (CRP) is a biomarker of an acute inflammatory
response and has been successfully used as a prognostic predictor for several …

被引用次数：24 相关文章

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

Y Zhang, L Lu, Z He, Z Xu, Z Xiang, RC Nie… - Frontiers in …, 2022 - cir.nii.ac.jp

抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> Serum C-reactive protein
(CRP) is a biomarker of an acute inflammatory response and has been successfully used as …

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

Y Zhang, L Lu, Z He, Z Xu, Z Xiang… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov

Background Serum C-reactive protein (CRP) is a biomarker of an acute inflammatory
response and has been successfully used as a prognostic predictor for several …

[HTML] nih.gov

[HTML][HTML] C-reactive protein levels predict responses to PD-1 inhibitors in hepatocellular carcinoma patients

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

[HTML][HTML] C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients.

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients.

引用

高级搜索

引用